|
|
MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast Cancer
|
|
김아영, 윤이나, Leem J, Lee JY, Jung KY, 강민성, 안지영, 황상구, Oh JS, 김재성
|
| Frontiers in oncology |
4.848(19) |
10:571601 / 2020 |
응용치료연구팀 |
33117702
|
|
|
Major Clues and Pitfalls in the Differential Diagnosis of Parathyroid and Thyroid Lesions Using Fine Needle Aspiration Cytology
|
|
하화정, 김은주, 김정순, 신명순, Noh I,박선후, 이승숙
|
| Medicina (Kaunas, Lithuania) |
1.205(19) |
56(11):E558 / 2020 |
병리과 |
33114338
|
|
|
Validation of the whole-body counting measurement in a radiation emergency
|
|
박민석, 김민섭, 유재룡, 조민수
|
| Applied radiation and isotopes |
1.270(19) |
2020 Oct 17. Epub ahead of print |
비상진료규제팀 |
33097379
|
|
|
Recent Survey of Effective Doses of F-18 FDG Torso PET/CT in Korea and the Current Recommendations for CT Protocols of PET/CT
|
|
Chong A, Park JM, ...김경민, Kim SM, Kim TS; Quality Control Committee of the Korean Society of Nuclear Medicine (KSNM); Korean Society of Nuclear Medicine Technology (KSNMT)
|
| Nuclear medicine and molecular imaging 핵의학분자영상 |
|
54(5):224-232 / 2020 |
의료용가속기연구팀 |
33088351
|
|
|
Impact of Dexmedetomidine on Tourniquet-Induced Systemic Effects in Total Knee Arthroplasty under Spinal Anesthesia: a Prospective Randomized, Double-Blinded Study
|
|
Lee C, Lee C, So C, 이지희, 최인성, Ma X, Hwang J.
|
| BioMed research international |
2.276(19) |
2020:4208597 |
마취통증의학과 |
33083465
|
|
|
Survival benefits from surgery of stage IVa head and neck squamous cell carcinoma: A multi-institutional analysis of 1033 cases
|
|
Park JO, Park YM, Jeong WJ, Shin YS, Hong YT, 최익준, Kim JW, Woo SH, Kim YS, Chang JW, Kim MS, Jung KY, Ahn SH, Kim CH, Hong KH, Chung PS, Kim YM, Kim SH, Baek SK.
|
| Clinical and experimental otorhinolaryngology |
1.979(19) |
2020 Sep 25. Epub ahead of print |
이비인후과 |
33081440
|
|
|
New Class of Efficient T2 Magnetic Resonance Imaging Contrast Agent: Carbon-Coated Paramagnetic Dysprosium Oxide Nanoparticles
|
|
Yue H, 박지애, Ho SL, Ahmad MY, Cha H, Liu S, Tegafaw T, Marasini S, Ghazanfari A, Kim S, Chae KS, Chang Y, Lee GH.
|
| Pharmaceuticals (Basel, Switzerland) |
4.286(19) |
13(10):312 / 2020 |
방사성의약품개발팀 |
33076332
|
|
|
Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer
|
|
Sim EJ, Ko KP, Ahn C, Park SM, Surh YJ, An S, Kim SW, Lee MH, Lee JW, Lee JE, Kim KS, Yom CK, 김현아, Park SK
|
| Breast cancer research and treatment |
3.831(19) |
184(2):615-626 / 2020 |
외과 |
33068197
|
|
|
Heart substructural dosimetric parameters and risk of cardiac events after definitive chemoradiotherapy for stage III non-small cell lung cancer
|
|
Jang BS, Cha MJ, Kim HJ, Oh S, Wu HG, 김은지, Kim BH, Kim JS, Chang JH.
|
| Radiotherapy and oncology |
4.856(19) |
2020 Oct 12. Epub ahead of print |
방사선종양학과 |
33058951
|
|
|
CB13, a novel PPARy ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer.
|
|
김태우, 홍다원, 홍성희
|
| Cell death & disease |
6.304(19) |
11(10): 848 / 2020 |
응용치료연구팀 외 |
33051435
|
